Hang Seng Index
CSPC Pharmaceutical Group
A large Chinese pharmaceutical group producing antibiotic APIs alongside branded oncology and cardiovascular drugs. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
1093.HK Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21+22.1%'22-3.6%'23-33.1%'24-18.4%'25+120.9%YTD-13.6%
Money in ▸·
CSPC Pharmaceutical Groupapprox. CN¥31.5B
▸ Money out·
Financials & Segments
- Total revenue · approx. CN¥31.5B (FY2023)
- Segments · Finished drugs (innovative) · Antibiotics API · Vitamin C & other APIs
Revenue from
No refined links yet.
Pays to
No refined links yet.